logo-loader
viewConcarlo Holdings, LLC

Concarlo Holdings using technology to fight drug resistance issues in breast cancer

Concarlo Holdings LLC Chief Scientific Officer Stacy Blain sat down with Christine Corrado from Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The Brooklyn, New York, company uses patented technologies to combat drug resistance in the treatment of breast cancer.
 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Thunderbird Entertainment sees strong third quarter results...

Thunderbird Entertainment (CVE: TBRD-OTC: THBRF) CEO Jennifer Twiner McCarron joined Steve Darling from Proactive Vancouver to share news the company has released their 3rd quarter financial numbers which saw a 40 per cent increase from Q-3 of last year. Twiner-McCarron talks about what led...

2 days, 5 hours ago

2 min read